307. カナバン病
[臨床試験数:3,薬物数:5(DrugBank:1),標的遺伝子数:0,標的パスウェイ数:0]

Searched query = "Canavan disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00657748
(ClinicalTrials.gov)
September 20099/4/2008Lithium and Acetate for Canavan DiseaseEvaluation of the Tolerance and Efficiency of a Combined Oral Therapy With Lithium and GTA in Patients With Canavan DiseaseCanavan Disease;Infantile;Deficiency Disease;Aspartoacylase;Leukodystrophy, SpongiformDrug: Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)Assistance Publique - Hôpitaux de ParisEuropean Leukodystrophy Association;European Leukodystrophy AssociationWithdrawn1 Year15 YearsBoth0Phase 2France
2NCT00724802
(ClinicalTrials.gov)
March 200818/6/2008Oral Glyceryl Triacetate (GTA) in Newborns With CanavanOral Glyceryl Triacetate (GTA) in Newborns With CanavanCanavan DiseaseDietary Supplement: GTA (Glyceryl triacetate);Drug: GTA glyceryl triacetateShaare Zedek Medical CenterNULLRecruitingN/A18 MonthsBoth1N/AIsrael
3NCT00278707
(ClinicalTrials.gov)
January 200615/1/2006GTA-Glyceryltriacetate for Canavan DiseasePhase 1 Treatment With GTA in Two Infant With Canavan DiseaseInfantile Canavan Disease;Deficiency Disease, AspartoacylaseDrug: GTA: GlyceryltriacetateSheba Medical CenterNULLActive, not recruitingN/A15 MonthsBoth5Phase 1Israel